实时应用药物遗传学指导华法林起始治疗：临床医生最新资讯 - Suppr

Suppr

超能文献

Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.

作者信息

Carlquist John F, Anderson Jeffrey L

机构信息

Intermountain Medical Center, Cardiovascular Department, 5121 S. Cottonwood Street, Murray, UT 84107-5701, USA.

出版信息

Circulation. 2011 Dec 6;124(23):2554-9. doi: 10.1161/CIRCULATIONAHA.111.019737.

DOI:10.1161/CIRCULATIONAHA.111.019737

PMID:22144632

Abstract

摘要

相似文献

Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.

Circulation. 2011 Dec 6;124(23):2554-9. doi: 10.1161/CIRCULATIONAHA.111.019737.

Pharmacogenetic-based dosing of warfarin.

Med Lett Drugs Ther. 2008 May 19;50(1286):39-40.

Warfarin and pharmacogenomic testing: what would Pascal do?

Pharmacotherapy. 2009 Mar;29(3):245-7. doi: 10.1592/phco.29.3.245.

Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.

J Am Med Dir Assoc. 2008 Mar;9(3):199-200. doi: 10.1016/j.jamda.2007.12.007.

Pharmacogenomic testing for warfarin dosing: we are ready now.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.

Pathology consultation on warfarin pharmacogenetic testing.

Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW.

Genetic testing for warfarin dosing? Not yet ready for prime time.

Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141.

Warfarin pharmacogenetics: ready for clinical utility?

Clin Lab Sci. 2009 Summer;22(3):151-5.

[Application of warfarin pharmacogenetics].

Vnitr Lek. 2009 Jun;55(6):565-9.

Dynamic pharmacogenetic models in anticoagulation therapy.

Clin Lab Med. 2008 Dec;28(4):539-52. doi: 10.1016/j.cll.2008.10.002.

引用本文的文献

Comparative performance of pharmacogenetics-based warfarin dosing algorithms in Chinese population: use of a pharmacokinetic/pharmacodynamic model to explore dosing regimen through clinical trial simulation.

Pharmacogenet Genomics. 2024 Dec 1;34(9):275-284. doi: 10.1097/FPC.0000000000000545. Epub 2024 Sep 12.

Novel Anticoagulant Treatment for Pulmonary Embolism with Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice.

Semin Intervent Radiol. 2018 Jun;35(2):83-91. doi: 10.1055/s-0038-1642622. Epub 2018 Jun 4.

VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.

Future Cardiol. 2018 Jan;14(1):15-26. doi: 10.2217/fca-2017-0025. Epub 2017 Dec 8.

Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis.

Biomed Res Int. 2015;2015:564149. doi: 10.1155/2015/564149. Epub 2015 Jan 6.

Drug-gene interactions: inherent variability in drug maintenance dose requirements.

P T. 2014 Sep;39(9):630-7.

Cardiovascular drugs and the genetic response.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):13-7. doi: 10.14797/mdcj-10-1-13.

Warfarin Dosing in a Patient with CYP2C9(∗)3(∗)3 and VKORC1-1639 AA Genotypes.

Case Rep Genet. 2014;2014:413743. doi: 10.1155/2014/413743. Epub 2014 Jan 22.

The emerging agenda of stratified medicine in neurology.

Nat Rev Neurol. 2014 Jan;10(1):15-26. doi: 10.1038/nrneurol.2013.245. Epub 2013 Dec 10.

Pharmacogenetic testing: Current Evidence of Clinical Utility.

Ther Adv Drug Saf. 2013 Aug 1;4(4):155-169. doi: 10.1177/2042098613485595.

Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients.

Clin Pharmacokinet. 2013 Nov;52(11):967-80. doi: 10.1007/s40262-013-0094-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.

作者信息

Carlquist John F, Anderson Jeffrey L

机构信息

Intermountain Medical Center, Cardiovascular Department, 5121 S. Cottonwood Street, Murray, UT 84107-5701, USA.

出版信息

Circulation. 2011 Dec 6;124(23):2554-9. doi: 10.1161/CIRCULATIONAHA.111.019737.

DOI:10.1161/CIRCULATIONAHA.111.019737

PMID:22144632

Abstract

摘要

相似文献

Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.

Circulation. 2011 Dec 6;124(23):2554-9. doi: 10.1161/CIRCULATIONAHA.111.019737.

Pharmacogenetic-based dosing of warfarin.

Med Lett Drugs Ther. 2008 May 19;50(1286):39-40.

Warfarin and pharmacogenomic testing: what would Pascal do?

Pharmacotherapy. 2009 Mar;29(3):245-7. doi: 10.1592/phco.29.3.245.

Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.

J Am Med Dir Assoc. 2008 Mar;9(3):199-200. doi: 10.1016/j.jamda.2007.12.007.

Pharmacogenomic testing for warfarin dosing: we are ready now.

Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.

Pathology consultation on warfarin pharmacogenetic testing.

Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW.

Genetic testing for warfarin dosing? Not yet ready for prime time.

Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141.

Warfarin pharmacogenetics: ready for clinical utility?

Clin Lab Sci. 2009 Summer;22(3):151-5.

[Application of warfarin pharmacogenetics].

Vnitr Lek. 2009 Jun;55(6):565-9.

Dynamic pharmacogenetic models in anticoagulation therapy.

Clin Lab Med. 2008 Dec;28(4):539-52. doi: 10.1016/j.cll.2008.10.002.

引用本文的文献

Pharmacogenet Genomics. 2024 Dec 1;34(9):275-284. doi: 10.1097/FPC.0000000000000545. Epub 2024 Sep 12.

Novel Anticoagulant Treatment for Pulmonary Embolism with Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice.

Semin Intervent Radiol. 2018 Jun;35(2):83-91. doi: 10.1055/s-0038-1642622. Epub 2018 Jun 4.

VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study.

Future Cardiol. 2018 Jan;14(1):15-26. doi: 10.2217/fca-2017-0025. Epub 2017 Dec 8.

Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis.

Biomed Res Int. 2015;2015:564149. doi: 10.1155/2015/564149. Epub 2015 Jan 6.

Drug-gene interactions: inherent variability in drug maintenance dose requirements.

P T. 2014 Sep;39(9):630-7.

Cardiovascular drugs and the genetic response.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):13-7. doi: 10.14797/mdcj-10-1-13.

Warfarin Dosing in a Patient with CYP2C9(∗)3(∗)3 and VKORC1-1639 AA Genotypes.

Case Rep Genet. 2014;2014:413743. doi: 10.1155/2014/413743. Epub 2014 Jan 22.

The emerging agenda of stratified medicine in neurology.

Nat Rev Neurol. 2014 Jan;10(1):15-26. doi: 10.1038/nrneurol.2013.245. Epub 2013 Dec 10.

Pharmacogenetic testing: Current Evidence of Clinical Utility.

Ther Adv Drug Saf. 2013 Aug 1;4(4):155-169. doi: 10.1177/2042098613485595.

Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients.

Clin Pharmacokinet. 2013 Nov;52(11):967-80. doi: 10.1007/s40262-013-0094-1.